Society for Endocrinology - a world-leading authority on hormones

News

New cardiovascular disease drug approved for use in UK

02 Sep 2021


Following clinical trials showing high effectiveness for inclisiran in treating heart disease, it has now been approved for use by NHS England. The twice yearly injection targets high cholesterol through RNA interference and is expected to prevent early deaths from heart disease and stroke.

Guardian